Navigation Links
Men with Enlarged Prostate and BPH Have Improved Options with Introduction of Urolift Procedure and 4KScore Prostate Cancer Test for Evaluation of Elevated PSA
Date:9/3/2014

NEW YORK, Sept. 3, 2014 /PRNewswire-USNewswire/ -- Symptoms of enlarged prostate affect millions of men, who suffer needlessly from frequent urination and difficulty emptying their bladder. Urinary tract obstruction from BPH can cause dangerous bladder problems in men including urinary retention, UTI and kidney failure.

According to Dr. Alex Shteynshlyuger, Director of Urology at New York Urology Specialists, "men with urinary problems should see an experienced urologist. Early treatment can prevent unpleasant complications." He adds that with modern treatment options such as the Urolift system for BPH and Greenlight laser, "the benefits are often dramatic and side effects are limited."

Urolift System for BPH and Enlarged Prostate is a same-day procedure that effectively treats men with BPH symptoms with few sexual side-effects of common BPH treatment options. For men who are not candidates for Urolift, other treatment options including Greenlight Laser are available.

For more information, visit: http://www.newyorkurologyspecialists.com/bph/urolift/

It is important to know that men with symptoms of enlarged prostate may have prostate cancer that can cause similar urinary symptoms.

Traditionally, the PSA test has been recommended for early detection of prostate cancer. Many men with mildly elevated PSA and symptoms of enlarged prostate do not have prostate cancer.

Recently, for men with elevated PSA, improved tests that include 4KScore as well as Prostate Health Index (PHI) have become available. These tests can replace the PSA test as they provide improved information and can help avoid unnecessary biopsies. 4K score prostate cancer test helps predict which men are more likely to have aggressive prostate cancer. 

About New York Urology Specialists

New York Urology Specialists is an independent urology practice offering state-of-the-art urology care for complex urological conditions including frequent urination in men, enlarged prostate and BPH, and prostate cancer care.

About Dr. Alex Shteynshlyuger

Dr. Alex Shteynshlyuger is a board-certified urologist who specializes in caring for men and women with complex urological problems. He serves as the Director of Urology at New York Urology Specialists. His research has been recognized nationally.  

For more information, visit New York Urology Specialists on Facebook and Google+

MEDIA CONTACT:  Dr. Alex Shteynshlyuger, 1-646-663-4252, media@NewYorkUrologySpecialists.com, http://www.newyorkurologyspecialists.com/about/

Logo - http://photos.prnewswire.com/prnh/20140408/NY00250LOGO

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
ProfNet - https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=115979


'/>"/>
SOURCE New York Urology Specialists
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
4. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
8. Breakthrough Prostate Cancer Diagnostics
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. Prostate Cancer and Bone Health
11. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... According to a new market research report "Life Science Analytics ... (Software, Service), Delivery (On premise, Cloud), End user (Pharmaceutical, Biotechnology, Medical ... is expected to reach USD 24.73 Billion by 2021 from USD ... forecast period. Continue Reading ... ...
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver Panel, Renal Panel, ... report to their offering. ... The global clinical laboratory testing market is expected to ... solutions on the grounds of maximum efficiency and minimum error is ...
(Date:1/20/2017)... 20, 2017  Palladian Health, a leading provider ... launch of an opioid management program which assists ... and helps stem the growing tide of dependence ... treat chronic non-cancer pain (back pain, neck pain, ... lack of evidence regarding long-term effectiveness. ...
Breaking Medicine Technology:
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats in ... its owner and founder. As Oat is recognized globally as one of the healthiest ... as he believes it is a move to sow the seed of good karma. ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa Orthopaedics (SRO) is ... at 167 Lynch Creek Way. The Petaluma office features three comfortable patient exam ... rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons Dr. Neema ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... raton florida (PRWEB) , ... January 20, 2017 , ... ... at the Dana Farber Cancer Institute. For Betsy, the clinical trial has been ... her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian cancer ...
Breaking Medicine News(10 mins):